Figure 2
From: Antithrombotic prevention in vascular disease: bases for a new strategy in antithrombotic therapy
Reducing inflammation with anti-inflammatory drugs and lower doses of standard therapies (heparin, aspirin, clopidogrel, and/or new antithrombotic drugs, prasugrel, dabigatran, rivaroxaban) could diminish thrombin formation and prevent thrombus growth with less frequent bleeding. This represents a possible alternative to current antithrombotic therapy offering similar efficacy and less bleeding complications.